Clinical Trial Update: Longitudinal TSPO PET Imaging With [18F]DPA-714 in PPMI (PPMI DPA-714 PET Imaging) [EARLY_Phase 1]

View source ↗

Summary

This clinical trials update describes a longitudinal TSPO PET imaging study using the [18F]DPA-714 tracer in people with Parkinson disease within the PPMI cohor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• [18F]DPA-714 (DPA-714)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Parkinson Disease | EARLY_Phase 1 | Status: RECRUITING